Suppression assays with human T regulatory cells: A technical guide
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
The suppression of inappropriate immune responses by Treg cells is one of the major ways that the body maintains immune tolerance and homeostasis. Since defects in the suppressive capacity of Treg cells underlie many different immune‐mediated diseases, there is great interest in developing ways to track the number and function of Treg cells as biomarkers of tolerance and in devising ways to enhance their function therapeutically. However, the methods of studying human Treg cells are fraught with technical challenges that can often lead to misinterpretation. The most common way to determine the suppressive capacity of human Treg cells is to measure their ability to suppress the proliferation of responding CD4 + T cells. Here, we discuss the technical considerations that must be taken into account when performing suppression of T‐cell proliferation assays with human Treg cells. We also consider how T cells may falsely appear suppressive because of dying cells in the system, improper resting of T‐cell lines prior to the assay, or insufficient proliferation of the responding T cells. We propose that, in the future, classification of a population of cells as “regulatory” should rely on more than a simple test for blockade of CD4 + T‐cell proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Currently the only way to confidently quantify human Tregs is to use a panel of different markers and then carry out parallel functional [381], gene expression [382], and/or epigenetic analyses [383, 384].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [381]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cutting Edge: Human Regulatory T Cells Require IL-35 To Mediate Suppression and Infectious Tolerance
Chaturvedi, V., Collison, L. W., Guy, C. S., Workman, C. J., & Vignali, D. A. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100315 · Cited by 205
RetractedPark, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606
FOXP3+ regulatory T cells in the human immune system
Sakaguchi, S., Miyara, M., Costantino, C. M., & Hafler, D. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2785 · Cited by 2,439
Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291
CD4+CD25high Regulatory Cells in Human Peripheral Blood
Baecher-Allan, C., Brown, J. A., Freeman, G. J., & Hafler, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1245 · Cited by 1,859
Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
Shevach, E. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.010 · Cited by 1,754
Research works printed but not linked: 2
- & 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu Eur. J. Immunol. 2012. 42: 27-34
- & 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu Eur. J. Immunol. 2012. 42: 27-34 45
Cited by
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity
Overacre-Delgoffe, A. E., Chikina, M., Dadey, R. E., Yano, H., Brunazzi, E. A., Shayan, G., Horne, W., Moskovitz, J. M., Kolls, J. K., Sander, C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.005 · Cited by 627
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Duell, J., Dittrich, M., Bedke, T., Mueller, T., Eisele, F., Rosenwald, A., Rasche, L., Hartmann, E., Dandekar, T., Einsele, H., et al. (2017) · Leukemia · doi:10.1038/leu.2017.41 · Cited by 278
Mesenchymal stromal cell apoptosis is required for their therapeutic function
Pang, S. H. M., D’Rozario, J., Mendonca, S., Bhuvan, T., Payne, N. L., Zheng, D., Hisana, A., Wallis, G., Barugahare, A., Powell, D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26834-3 · Cited by 245
Araya, P., Waugh, K. A., Sullivan, K. D., Núñez, N. G., Roselli, E., Smith, K. P., Granrath, R. E., Rachubinski, A. L., Enriquez Estrada, B., Butcher, E. T., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908129116 · Cited by 179
“Suppression was then calculated as previously described (1) with the formula % Suppression = 100-(DITreg/DICtrl) x 100% (DITreg stands for the division index of responder cells with Tregs, and DICtrl stands for the division index of responder cells activated without Tregs).”
MethodLAG3 limits regulatory T cell proliferation and function in autoimmune diabetes
Zhang, Q., Chikina, M., Szymczak-Workman, A. L., Horne, W., Kolls, J. K., Vignali, K. M., Normolle, D., Bettini, M., Workman, C. J., & Vignali, D. A. A. (2017) · Science Immunology · doi:10.1126/sciimmunol.aah4569 · Cited by 164
The Environment of Regulatory T Cell Biology: Cytokines, Metabolites, and the Microbiome
Hoeppli, R. E., Wu, D., Cook, L., & Levings, M. K. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00061 · Cited by 176
Self-citationDawson, N. A. J., Rosado-Sánchez, I., Novakovsky, G. E., Fung, V. C. W., Huang, Q., McIver, E., Sun, G., Gillies, J., Speck, M., Orban, P. C., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz3866 · Cited by 147
Self-citationScurr, M., Ladell, K., Besneux, M., Christian, A., Hockey, T., Smart, K., Bridgeman, H., Hargest, R., Phillips, S., Davies, M., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.62 · Cited by 127
Kim, S. T., Chu, Y., Misoi, M., Suarez-Almazor, M. E., Tayar, J. H., Lu, H., Buni, M., Kramer, J., Rodriguez, E., Hussain, Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29539-3 · Cited by 129
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance
van Gulijk, M., van Krimpen, A., Schetters, S., Eterman, M., van Elsas, M., Mankor, J., Klaase, L., de Bruijn, M., van Nimwegen, M., van Tienhoven, T., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.abn6173 · Cited by 110
Kadowaki, A., Miyake, S., Saga, R., Chiba, A., Mochizuki, H., & Yamamura, T. (2016) · Nature Communications · doi:10.1038/ncomms11639 · Cited by 102
The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer
Ward, S., Li, K. K., Hepburn, E. A., Weston, C. J., Curbishley, S. M., Reynolds, G. M., Hejmadi, R. K., Bicknell, R., Eksteen, B., Ismail, T., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.572 · Cited by 111
“Results were reported as percent suppression (McMurchy and Levings, 2012):”
MethodDawson, N. A. J., Lamarche, C., Hoeppli, R. E., Bergqvist, P. J., Fung, V. C. W., McIver, E., Huang, Q. B., Gillies, J. K., Speck, M., Orban, P. C., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.123672 · Cited by 135
Self-citationLuo, Y., Xu, Z., Wang, B., Niu, Q., Su, X., Bai, Y., Zhu, S., Zhao, C., Sun, Y., Wang, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24213-6 · Cited by 111
Shao, Y., Yang, W. Y., Saaoud, F., Drummer, C., Sun, Y., Xu, K., Lu, Y., Shan, H., Shevach, E. M., Jiang, X., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.152511 · Cited by 95
“Of note, the marked changes were observed in the high ratios of Tregs to Teffs, which may not be physiologically relevant (97).”
Cook, L. E., Munier, C. M. L., Seddiki, N., van Bockel, D. J., Ontiveros, N., Hardy, M. Y., Gillies, J. K., Levings, M. K., Reid, H. H., Petersen, J., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.02.015 · Cited by 91
Self-citationYan, L., Hu, F., Yan, X., Wei, Y., Ma, W., Wang, Y., Lü, S., & Wang, Z. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1414-3 · Cited by 88
Bender, C., WIEDEMAN, A. E., Hu, A. K., Ylescupidez, A., Sietsema, W. K., Herold, K. C., Griffin, K., Gitelman, S. E., Long, S. A., on behalf of the T-Rex Study Group†, et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adn2404 · Cited by 94
“Percent suppression was calculated using the conventional method [% suppression = 100 − (T convs + T regs /T convs only) × 100] ( 57 ).”
MethodHarnessing the biology of regulatory T cells to treat disease
Wardell, C. M., Boardman, D. A., & Levings, M. K. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01089-x · Cited by 100
“Second, activated effector T cells can also exhibit suppressor-like activity via unknown mechanisms 81 .”
Self-citationAdoptive therapy with amyloid-β specific regulatory T cells alleviates Alzheimer's disease
Yang, H., Park, S., Baek, H., Lee, C., Chung, G., Liu, X., Lee, J. H., Kim, B., Kwon, M., Choi, H.-J., et al. (2022) · Theranostics · doi:10.7150/thno.75965 · Cited by 104
“After 3 days, Teff proliferation was analyzed as previously described [7].”
ITK signalling via the Ras/IRF4 pathway regulates the development and function of Tr1 cells
Huang, W., Solouki, S., Koylass, N., Zheng, S. G., & August, A. (2017) · Nature Communications · doi:10.1038/ncomms15871 · Cited by 77
“The percentage of suppression (PS) under condition i was defined as ‘PS i ¼ 100 (cid:4) (1–DI i /DI 0 )’ 61 .”
Bhattacharjee, A., Burr, A. B. P., Overacre-Delgoffe, A. E., Tometich, J. T., Yang, D., Huckestein, B. R., Linehan, J. L., Spencer, S. P., Hall, J. A., Harrison, O. J., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.07.005 · Cited by 80
Duggleby, R. C., Danby, R., Madrigal, J. A., & Saudemont, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00252 · Cited by 79
Seddiki, N., Cook, L., Hsu, D. C., Phetsouphanh, C., Brown, K., Xu, Y., Kerr, S. J., Cooper, D. A., Munier, C. M. L., Pett, S., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201344102 · Cited by 66
IL-23 stabilizes an effector Treg cell program in the tumor microenvironment
Wertheimer, T., Zwicky, P., Rindlisbacher, L., Sparano, C., Vermeer, M., de Melo, B. M. S., Haftmann, C., Rückert, T., Sethi, A., Schärli, S., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01755-7 · Cited by 73
Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B
Koristka, S., Cartellieri, M., Arndt, C., Bippes, C. C., Feldmann, A., Michalk, I., Wiefel, K., Stamova, S., Schmitz, M., Ehninger, G., et al. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.01.002 · Cited by 67
Control of tissue‐localized immune responses by human regulatory T cells
Pesenacker, A. M., Broady, R. C., & Levings, M. K. (2014) · European Journal of Immunology · doi:10.1002/eji.201344205 · Cited by 58
Self-citationSubstrate stiffness enhances human regulatory T cell induction and metabolism
Shi, L., Lim, J. Y., & Kam, L. C. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2022.121928 · Cited by 54
Gilmore, W., Lund, B. T., Li, P., Levy, A. M., Kelland, E. E., Akbari, O., Groshen, S. G., Cen, S., Pelletier, D., Weiner, L. P., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01847-9 · Cited by 57
Wang, Z. X., Wang, C. Q., Li, X. Y., Feng, G., Zhu, H., Ding, Y., & Jiang, X. J. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2272-3 · Cited by 51
“To assess the activity and function of CD4CD25 Tregs, we performed the in vitro suppression of T-cells proliferation assay, as described previously [20, 21].”
Impaired inhibitory function of circulating CD4+CD25+ regulatory T cells in alopecia areata
Shin, B. S., Furuhashi, T., Nakamura, M., Torii, K., & Morita, A. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.01.006 · Cited by 49
Regulatory T cells converted from Th1 cells in tumors suppress cancer immunity via CD39
Tan, S.-N., Hao, J., Ge, J., Yang, Y., Liu, L. H., Jia, H., Lin, M., Zhao, X., Wang, G., Yang, Z., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20240445 · Cited by 63
Akimova, T., Levine, M. H., Beier, U. H., & Hancock, W. W. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3139-2_4 · Cited by 43
“There is a great variability in conditions of Treg suppression assays [17], and multiple factors may affect the results [11].”
BackgroundCampos‐Mora, M., Solminihac, J. D., Rojas, C., Padilla, C. R., Kurte, M., Pacheco, R., Kaehne, T., Wyneken, Ú., & Pino‐Lagos, K. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12237 · Cited by 44
“Suppression was calculated as previously described (Mcmurchy & Levings, 2012).”
Avian CD4+CD25+ regulatory T cells: Properties and therapeutic applications
Selvaraj, R. K. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.04.018 · Cited by 50
Dai, Z., Wang, E. H. C., Petukhova, L., Chang, Y., Lee, E. Y., & Christiano, A. M. (2021) · Science Advances · doi:10.1126/sciadv.abd1866 · Cited by 46
“11 of 13 and the percent suppression was calculated according to previous reports (55).”
MethodTjon, A. S. W., Tha‐In, T., Metselaar, H. J., van Gent, R., van der Laan, L. J. W., Groothuismink, Z. M. A., Boekhorst, P. A. W. T., van Hagen, P. M., & Kwekkeboom, J. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12102 · Cited by 41
Huang, L., Yao, Y.-M., Li, J., Zhang, S., Li, W., Dong, N., Yu, Y. H., & Sheng, Z.-Y. (2012) · Fitoterapia · doi:10.1016/j.fitote.2012.08.019 · Cited by 41
Barra, J. M., Robino, R. A., Castro-Gutiérrez, R., Proia, J., Russ, H. A., & Ferreira, L. M. R. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114994 · Cited by 42
Cabral-Marques, O., Schimke, L. F., de Oliveira, E. B., Khawanky, N. E., Ramos, R. N., al-Ramadi, B. K., Segundo, G. R. S., Ochs, H. D., & Condino‐Neto, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02742 · Cited by 43
Identification, Isolation, and Functional Assay of Regulatory T Cells
Azimi, M., Aslani, S., Mortezagholi, S., Farrokhi, A. S., Javan, M. R., Rezaiemanesh, A., Ghaedi, M., Gholamzad, M., & Salehi, E. (2016) · Immunological Investigations · doi:10.1080/08820139.2016.1193869 · Cited by 39
“With both approaches, a successful program of therapy depends critically on accurate assessment of the suppressive capability of Tregs immediately before administration into patients (Brusko et al., 2007; Canavan et al., 2012; McMurchy & Levings 2012).”
BackgroundMethodInfluentialCampos‐Mora, M., Contreras‐Kallens, P., Gálvez‐Jirón, F., Rojas, M., Rojas, C., Refisch, A., Cerda, O., & Pino‐Lagos, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00882 · Cited by 35
“Suppression was calculated as previously described (53).”
First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant
Bernaldo-de-Quirós, E., Camino, M., Martínez‐Bonet, M., Gil‐Jaurena, J., Gil, N., Hernández-Flórez, D., Fernández‐Santos, M. E., Laiseca, L. B., Dijke, E., Levings, M. K., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20231045 · Cited by 40
“After 3 days, cells were analyzed by flow cytometry and the percentage suppression of proliferation was calculated according to the “ Division index method ” (McMurchy and Levings, 2012) within CD4 + and CD8 + T cells.”
MethodSelf-citationProgress in Translational Regulatory T Cell Therapies for Type 1 Diabetes and Islet Transplantation
Marfil‐Garza, B. A., Hefler, J., de León, M. B., Pawlick, R. L., Dadheech, N., & Shapiro, A. M. J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa028 · Cited by 36
Biomimetic tolerogenic artificial antigen presenting cells for regulatory T cell induction
Rhodes, K. R., Meyer, R. A., Wang, J. G., Tzeng, S. Y., & Green, J. J. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.06.004 · Cited by 32
“To calculate the percent suppression, the division index (DI), or the average number of divisions undergone by responder cells, was calculated in FlowJo, then the following equation was used: 100 – (DIsample / DIcontrol) x 100, where the control is proliferation of responder cells in the absence of suppressors.[26]”
MethodBernaldo-de-Quirós, E., Cózar, B., López-Esteban, R., Clemente, M., Gil‐Jaurena, J., Pardo, C., Pita, A., Pérez–Caballero, R., Camino, M., Gil, N., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.893576 · Cited by 36
Treg in inborn errors of immunity: gaps, knowns and future perspectives
Kennedy-Batalla, R., Acevedo, D., Luo, Y., Esteve‐Solé, A., Vlagea, A. D., Correa‐Rocha, R., Seoane-Reula, E., & Alsina, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1278759 · Cited by 39
“By basing it on cell divisions rather than the total number of cells, the calculation of the division index allows for a more accurate assessment (36).”
BackgroundBrezar, V., Ruffin, N., Richert, L. E., Surénaud, M., Lacabaratz, C., Palucka, K., Thiébaut, R., Banchereau, J., Lévy, Y., & Seddiki, N. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004752 · Cited by 33
Zare, M., Jahromi, B. N., & Gharesi‐Fard, B. (2019) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2019.06.002 · Cited by 32
Baatjes, A. J., Smith, S. G., WATSON, R. M., Howie, K. J., Murphy, D. M., Larché, M., Denburg, J. A., Inman, M. D., & O’Byrne, P. M. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12594 · Cited by 30
Sharma, V., Sachdeva, N. K., Gupta, V., Nada, R., Jacob, J., Sahni, D., & Aggarwal, A. (2021) · Scandinavian Journal of Immunology · doi:10.1111/sji.13107 · Cited by 30
Mota, C., Silva, V. M. D. S., Pires, A. R., Matoso, P., Victorino, R. M. M., Sousa, A. E., & Caramalho, Í. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400198 · Cited by 27
“suppressive function of iTreg (27), using as a control population freshly isolated circulating Treg (CD4CD25CD127, 80–90% of them expressing FOXP3).”
MethodReddy, P. B. J., Schreiber, T. H., Rajasagi, N. K., Suryawanshi, A. S., Mulik, S., Veiga‐Parga, T., Niki, T., Hirashima, M., Podack, E. R., & Rouse, B. T. (2012) · Journal of Virology · doi:10.1128/jvi.01391-12 · Cited by 33
“Percent suppression by Tregs was calculated by using the formula 100 [(frequency of cells proliferated at a particular Treg/effector T cell ratio)/(frequency of cells proliferated in the absence of Tregs)]100 (12).”
MethodEx vivo delivery of regulatory T-cells for control of alloimmune priming in the donor lung
Miyamoto, E., Takahagi, A., Ohsumi, A., Martinu, T., Hwang, D. M., Boonstra, K. M., Joe, B., Umaña, J. M., Bei, K. F., Vosoughi, D., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.00798-2021 · Cited by 28
Sidhu-Varma, M., Shih, D. Q., & Targan, S. R. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000653 · Cited by 28
“Percent suppression was calculated as described earlier.(24)”
Schmidt, A., Éliás, S., Joshi, R. N., & Tegner, J. N. (2016) · Journal of Visualized Experiments · doi:10.3791/55015 · Cited by 52
Review of flow cytometry as a tool for cell and gene therapy
Lazarski, C. A., & Hanley, P. J. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2023.10.005 · Cited by 25
Immune monitoring as prerequisite for transplantation tolerance trials
Sani, K. B., & Sawitzki, B. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12988 · Cited by 26
Role of Regulatory T Cells in Tubercular Uveitis
Sharma, R. K., Gupta, A., Kamal, S., Bansal, R., Singh, N., Sharma, K., Virk, S., & Sachdeva, N. K. (2016) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2016.1196711 · Cited by 23
“Percentage suppression by Tregs was calculated as previously described.(17)”
MethodHaribhai, D., Luo, X., Chen, J., Jia, S., Shi, L., Schroeder, J. A., Weiler-Guettler, H., Aster, R. H., Hessner, M. J., Hu, J., et al. (2016) · Blood Advances · doi:10.1182/bloodadvances.2016001453 · Cited by 28
Regulatory T-cells drive immune dysfunction in CLL
Lad, D. P., Hoeppli, R. E., Huang, Q., García, R., Xu, L., Toze, C. L., Broady, R. C., & Levings, M. K. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1330475 · Cited by 23
“conditions [13] would be needed for comprehensive”
Self-citationAlvarez-Salazar, E. K., Cortés-Hernández, A., Arteaga-Cruz, S., Alberú, J., & Soldevila, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00375 · Cited by 21
Death receptor 3 signaling enhances proliferation of human regulatory T cells
Bittner, S., Knoll, G., & Ehrenschwender, M. (2017) · FEBS Letters · doi:10.1002/1873-3468.12632 · Cited by 21
Hamari, S., Kirveskoski, T., Glumoff, V., Kulmala, P., Simell, O., Knip, M., & Veijola, R. (2016) · Scandinavian Journal of Immunology · doi:10.1111/sji.12418 · Cited by 22
Wang, W., Wei, C., Cheng, Z., & Yang, J. (2020) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2020.12.6.1029 · Cited by 22
Wang, Z. X., Wang, C. Q., Li, X. Y., Ding, Y., Feng, G., & Jiang, X. J. (2015) · International Heart Journal · doi:10.1536/ihj.14-245 · Cited by 19
A novel and rapid method to quantify Treg mediated suppression of CD4 T cells
Long, A. E., Tatum, M., Mikacenic, C. R., & Buckner, J. H. (2017) · Journal of Immunological Methods · doi:10.1016/j.jim.2017.06.009 · Cited by 19
“Methods include measuring cell proliferation (thymidine incorporation or CFSE dye dilution); cytokine production (typically IFNγ and TNFα) (McMurchy and Levings, 2012); and activation markers (CD69 and CD154) on the cell surface (Canavan et al.”
BackgroundCandía, E., Reyes, P., Covián, C., Rodriguez, F., Wainstein, N., Morales, J., Mosso, C., Rosemblatt, M. S., & Fierro, J. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182009 · Cited by 20
Semaphorin 4A Stabilizes Human Regulatory T Cell Phenotype via Plexin B1
Chapoval, S. P., Hritzo, M. K., Qi, X., Tamagnone, L., Golding, A., & Keegan, A. D. (2019) · ImmunoHorizons · doi:10.4049/immunohorizons.1800026 · Cited by 19
“Percent suppression of Tresp cell proliferation for eachTreg cell dosewas calculatedusing a conventional method where [100 2 (% divided Tresp cells cultured alone/% divided Tresp cells in cultures with Treg cells) 3 100] = % suppression (30).”
MethodSingle cell suppression profiling of human regulatory T cells
Søndergaard, J. N., Tulyeu, J., Priest, D., Sakaguchi, S., & Wing, J. B. (2025) · Nature Communications · doi:10.1038/s41467-024-55746-1 · Cited by 18
Han, S., Chung, D. C., Paul, M. S., Liu, Z. Q., Garcia-Batres, C. R., Elford, A. R., Tran, C. W., Chapatte, L., & Ohashi, P. S. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1737368 · Cited by 25
“without Tregs) x 100).(48) While Cbl-b KO CD4FoxP3 T cells intrinsically possessed enhanced proliferative capacity,”
BackgroundCell exhaustion in HIV-1 infection: role of suppressor cells
Seddiki, N., Brezar, V., & Draenert, R. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000087 · Cited by 16
“Unau 1746-630X 2014 Wolters Kluwer Health | Lippincott Williams & Wilki are the only practicable and available tool while studying the function of Tregs [2].”
MethodLo, T.-C., Cheng, J., Lee, C., Hung, J., Lin, C., Yeh, H.-F., Yang, B.-C., Huang, Y., Wu, H., Yu, A. L.-T., et al. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.09.012 · Cited by 15
Expression of IL-37 Induces a Regulatory T-Cell-like Phenotype and Function in Jurkat Cells
Osborne, D. G., Domenico, J. M., & Fujita, M. (2022) · Cells · doi:10.3390/cells11162565 · Cited by 16
“Percent suppression was calculated using the equation, % suppression = 100 − (X/Y)100, X represents the division index (DI) of Tresp with Jurkat/Treg cells, and Y is the average DI of Tresp cells alone, as in [15].”
MethodHaensgen, H., Albornoz, E. A., Opazo, M. C., Bugueño, K., Jara, E. L., Binzberger, R., Rivero-Castillo, T., Luis, V. S., Simón, F., Cabello‐Verrugio, C., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01257 · Cited by 13
Carden, M. A., Connelly, J. A., Weinzierl, E. P., Kobrynski, L. J., & Chandrakasan, S. (2018) · Journal of Clinical Immunology · doi:10.1007/s10875-018-0518-7 · Cited by 13
Improving regulatory T cell production through mechanosensing
Shi, L., Lim, J. Y., & Kam, L. C. (2024) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37702 · Cited by 15
Tuomela, K., García, R., Boardman, D. A., Tavakoli, P., Ancheta-Schmit, M., Sham, H. P., Cheng, L., Struthers, M. D., Bressler, B. L., Vallance, B. A., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102303 · Cited by 20
Self-citationTissue‐resident regulatory T cells accumulate at human barrier lymphoid organs
Hewavisenti, R., Ferguson, A. L., Gasparini, G., Ohashi, T., Braun, A., Watkins, T. S., Miles, J. J., Elliott, M., Sierro, F., Feng, C. G., et al. (2021) · Immunology and Cell Biology · doi:10.1111/imcb.12481 · Cited by 12
“This was then used to calculate the percentage suppression: (% Suppression = 100 ((DI of Treg + CD8 co-culture)/DI of CD8 alone) 9 100).(40)”
MethodSato, Y., Osada, E., & Manome, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22911 · Cited by 13
Keltsch, E., Greiner, J., Wahl, L., Knape, I., Tews, D., Denkinger, M. D., Debatin, K., & Strauß, G. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00524-w · Cited by 12
“Likewise, the proliferation and division index was defined with FlowJo software (10.8.1) [21].”
InfluentialAssessment of Functional Immune Responses in Lymphocytes
Abraham, R. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-7020-6896-6.00093-4 · Cited by 15
Paul, M., Dayal, D., Bhansali, A. K., Dhaliwal, L., & Sachdeva, N. K. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.09.004 · Cited by 12
Lauener, M. P., Azadpour, S., Abdossamadi, S., Parthasarathy, V., Ng, B., Ostroumov, E., Cuvelier, G. D. E., Levings, M. K., MacDonald, K. N., Kariminia, A., et al. (2022) · Haematologica · doi:10.3324/haematol.2022.280653 · Cited by 10
“However, NKreg cells do not appear to suppress Treg cells or CD8 + T cells, suggesting that NKreg cells selectively regulate T cell subsets, differentiating their function from Treg cells which strongly suppress both CD4 and CD8 T cells.(20) This finding may correlate to NK cells”
BackgroundSelf-citationLactic acid improves Treg manufacturing and in vivo function
Tuomela, K., Leong, E. S. Y., Haque, M., Mangat, S., Fung, V. C. W., García, R., Archambault, A., Boardman, D. A., Geltink, R. I. K., Mojibian, M., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101600 · Cited by 13
Self-citationKhamri, W., Gudd, C. L. C., Liu, T., Nathwani, R., Krasniqi, M., Azam, S., Barbera, T. A., Trovato, F. M., Possamai, L. A., Triantafyllou, E., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324071 · Cited by 12
A method for conducting suppression assays using small numbers of tissue-isolated regulatory T cells
Ward, S., Li, K., & Curbishley, S. M. (2014) · MethodsX · doi:10.1016/j.mex.2014.08.012 · Cited by 9
“Results were reported as percent suppression [3]:”
Gallego-Valle, J., Gil-Manso, S., Pita, A., Bernaldo-de-Quirós, E., López-Esteban, R., Martínez‐Bonet, M., Pérez-Fernández, V. A., Pérez–Caballero, R., Pardo, C., Gil‐Jaurena, J., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9050461 · Cited by 11
“To calculate the percentage of suppression of proliferation, the division index method was used as previously described in [32].”
MethodCortés-Hernández, A., Alvarez-Salazar, E. K., Arteaga-Cruz, S., Rosas-Cortina, K., Linares, N., Gómez, J. M. A., & Soldevila, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.686530 · Cited by 11
Engineering of regulatory T cells by means of mRNA electroporation in a GMP-compliant manner
Janssens, I., Campillo-Davó, D., den Bos, J. V., Reu, H. D., Berneman, Z. N., Wens, I., & Cools, N. (2022) · Cytotherapy · doi:10.1016/j.jcyt.2022.01.001 · Cited by 11
Maternal Type 1 Diabetes Reduces Autoantigen-Responsive CD4+ T Cells in Offspring
Knoop, J., Eugster, A., Gavrisan, A., Lickert, R., Sedlmeier, E., Dietz, S., Lindner, A., Warncke, K., Hummel, N., Ziegler, A., et al. (2020) · Diabetes · doi:10.2337/db19-0751 · Cited by 11
“These findings require validation since gene expression does not define Treg and suppression assays are crude measures of Treg activity and are affected by many confounders, including T effector function (50).”
BackgroundSharma, R. K., Sehgal, S., Sachdeva, N. K., Kumar, R., & Gupta, A. (2018) · Immunological Investigations · doi:10.1080/08820139.2018.1515223 · Cited by 10
Sharma, R. K., Sharma, J., Khan, Z. K., Pattekar, A., Gupta, V., Bansal, R., Sharma, K., Aggarwal, A. N., Gupta, A., & Sachdeva, N. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-32234-3 · Cited by 8
Ferreira, V. D. S., Mesquita, F. V., Mesquita, D., & Andrade, L. E. C. (2015) · Cryobiology · doi:10.1016/j.cryobiol.2015.10.149 · Cited by 8
Nam, M. (2025) · Clinical Transplantation and Research · doi:10.4285/ctr.25.0040 · Cited by 10
“The suppressive function of Tregs is commonly assessed with in vitro proliferation-based assays, such as [³H]-thymidine incorporation and carboxyfluorescein suc-cinimidyl ester (CFSE) dye dilution [85,86].”
Kommoju, V., Mariaselvam, C. M., Bulusu, S. N., Reni, B. N., Kavadichanda, C. G., Thabah, M. M., & Negi, V. S. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106859 · Cited by 7
Mechanistic and Biomarker Studies to Demonstrate Immune Tolerance in Multiple Sclerosis
Docampo, M. J., Lutterotti, A., Sospedra, M., & Martinꝉ, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.787498 · Cited by 9
Regulatory T cell properties of thymic CD4+ CD25+ cells in turkeys
Shanmugasundaram, R., & Selvaraj, R. K. (2012) · Poultry Science · doi:10.3382/ps.2012-02202 · Cited by 7
“The T cell proliferation suppression assay is one gold standard assay used to determine the suppressive properties of Tregs (McMurchy and Levings, 2012), and because turkey CD4+CD25+ cells can suppress T cell proliferation, they are most likely the counterparts of mammalian Tregs.”
Method
Metadata
- Authors
- McMurchy, A. N., & Levings, M. K.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- Levings, Megan K.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2011-12-12
- Volume
- 42
- Issue
- 1
- Pages
- 27-34
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1963511922
- Cited by
- 147
- References
- 64
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 14 · 2023: 6 · 2022: 12 · 2021: 15 · 2020: 12 · 2019: 12 · 2018: 7 · 2017: 11 · 2016: 11 · 2015: 7 · 2014: 10 · 2013: 6 · 2012: 4
- FWCI
- 0.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Michael Smith Health Research BC
- Roche Organ Transplant Research Foundation
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- regulatory T cells, Treg suppressive function, CD4+ T cells, immune tolerance, immune-mediated diseases
- MeSH terms
- Flow Cytometry, Humans, Immune Tolerance, T-Lymphocytes, Regulatory, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.